PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 “EPNEC” study

BACKGROUND: Few data are available on programmed cell-death-protein-1–ligand-1 (PD-L1) expression on large-cell neuroendocrine carcinomas of the lung (LCNECs). We analyzed PD-L1 expression on tumor (TCs) and inflammatory cells (ICs) from LCNEC patients to assess relationships between this expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Arpin, Dominique, Charpentier, Marie-Christine, Bernardi, Marie, Monnet, Isabelle, Boni, Aurelie, Watkin, Emmanuel, Goubin-Versini, Isabelle, Lamy, Régine, Gérinière, Laurence, Geier, Margaux, Forest, Fabien, Gervais, Radj, Madrosyk, Anne, Guisier, Florian, Serrand, Cécile, Locher, Chrystèle, Decroisette, Chantal, Fournel, Pierre, Auliac, Jean-Bernard, Jeanfaivre, Thierry, Letreut, Jacques, Doubre, Hélène, Francois, Geraldine, Piton, Nicolas, Chouaïd, Christos, Damotte, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343361/
https://www.ncbi.nlm.nih.gov/pubmed/32684990
http://dx.doi.org/10.1177/1758835920937972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343361/
https://www.ncbi.nlm.nih.gov/pubmed/32684990
http://dx.doi.org/10.1177/1758835920937972

Ejemplares similares